Search
Rethinking How Cancer Cells Evade Targeted Therapy
Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.UCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies
In a study published December 8, 2022 in Science, UCSF researchers Kevin Lou, an MD-PhD student, Luke Gilbert, PhD, and Kevan Shokat, PhD, reveal the discovery of a cellular uptake pathway important for larger molecules.UCSF Researchers Develop Prediction Model of Aortic Aneurysm
Ascending thoracic aortic disease is an important cause of sudden death in the U.S., yet most aortic aneurysms are identified incidentally.Better Cancer Care: Pearls From the Best Studies of 2022
Focusing on blood, breast and lung cancers, our specialists deliver exciting findings from the latest phase III trials.UCSF Health Reaches 20,000 Organ Transplants
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.Advanced Heart Failure Comprehensive Care Center Physician Pocket Card
Referral guide and contact information for advanced heart failure specialists at UCSF.Cutting-Edge Approaches to Prostate and Breast Cancers: Reach the Right Decision for Each Patient
In this grand rounds presentation, you’ll learn the best risk assessment tools for prostate cancer patients, the latest surgical techniques, such as fluorescence imaging and high-intensity focused ultrasound, and tests that allow for matching patients with appropriate options.Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future TherapiesMigraine Sufferers Are Prone to BPPV at an Earlier Age, Study Finds
Migraine predisposes individuals to developing benign paroxysmal positional vertigo (BPPV) earlier in life than those without migraine, according to a UCSF study.Cerebrovascular Neurosurgery
As one of the highest volume and most experienced surgical programs in the nation for cerebrovascular disorders, we offer a wide range of treatment options tailored to each patient, leading to safer surgeries and better outcomes.Screening and Removal of Precancerous Lesions Prevents Anal Cancer
National study led by UCSF is first to show effectiveness of simple strategies to reduce risk of often silent cancer.UCSF Sheds Light on the Reasons Behind Sex Differences in Myocarditis
This study suggests mechanisms behind why myocarditis associated with cancer immunotherapies may occur more frequently in female patients.Louder for the Patients in the Back: Making the Most of New Hearing Aid Options
Hearing loss is associated with cognitive decline, so finding solutions that help patients stay socially connected is crucial.Assessing Cognitive Decline in Primary Care: New Tools and Algorithms for Everyday Practice
Although timely diagnosis can significantly improve a patient’s future, dementia is underdiagnosed and often detected late.UCSF Surgeons Perform First Pure Robotic Whipple Surgery in the Bay Area
Gastrointestinal surgeons at UC San Francisco have performed the first pure robotically assisted Whipple surgery in San Francisco.UCSF Launches Initiative to Address Disparities in Pulse Oximetry Performance
This project seeks to improve accuracy for patients with darker skin pigmentation.UCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA
UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States.Advanced Heart Failure Comprehensive Care Center
The Advanced Heart Failure Comprehensive Care Center (AHF CCC) at UCSF offers coordinated and comprehensive care for heart failure patients.New Guidance for Reducing Medication-Related Dementia Risk in Patients With Overactive Bladder
This consensus paper is designed to update urologists and other healthcare providers who prescribe anticholinergics about the risks of these medications and help guide them on when to use anticholinergics and when it is appropriate to use alternatives.The First Patient-Centered Sialadenitis Assessment Tool
A new standardized measure of symptoms associated with salivary duct obstruction was recently developed by researchers, including UCSF otolaryngologists Jolie Chang, MD, FACS, and William R. Ryan, MD, FACS, and UCSF medical student Arushi Gulati.Spine Center
The UCSF Spine Center offers comprehensive management for all disorders of the spine, spinal cord and nerve roots.Vestibular Migraine (and Conditions That Look Like It): Paths to Diagnosis and Care
In this guide to efficient diagnosis and effective therapeutics, otolaryngologic surgeon Caroline Schlocker, MD, walks providers through her rule-out process and clarifies criteria for vestibular migraine.Urinary Misery: How to Help Female Patients With Persistent Dysuria
In this resource-packed talk, urogynecologist Caitlyn E. Painter, DO, explains how to categorize causes, what to understand about urine cultures and other tests, and the latest evidence on which treatments help patients.Autoantibody for Acquired Lipodystrophy Identified, Bringing Hope for Therapeutics
UCSF investigators have found an autoantibody biomarker for acquired lipodystrophy, paving the way for novel treatment options for this complex condition, which causes adipose tissue loss and metabolic complications.